We will create a new class of cancer radiotherapy system that solves the complex problem of how to target a tumour with precision and accuracy even as the patient’s anatomy changes during treatment. Our Nano-X system is built with real-time imaging guidance and treatment adaptation at the heart of the design process; and complex processing tasks have been moved from hardware to software, enabling radical changes to machine design. Together these innovations will ensure better treatment outcomes.
X-Tream: A Realtime X-ray Treatment Monitoring And Dosimetry System For Submillimetric Radiosurgery
Funder
National Health and Medical Research Council
Funding Amount
$408,544.00
Summary
We plan to develop a commercial prototype of a new clinical product called X-Tream, together with pre-clinical experimental and Monte Carlo data to demonstrate its performance in one potential clinical application involving an exciting and rapidly developing radiosurgery technique known as microbeam radiation therapy. We intend to show that the X-Tream system has the demonstrated ability to provide essential measurements with the necessary accuracy to allow for future clinical trials.
Breathe Well: Improving Cancer Imaging And Targeted Radiotherapy Using Audiovisual Biofeedback
Funder
National Health and Medical Research Council
Funding Amount
$606,847.00
Summary
Irregular breathing causes anatomical errors in medical images and consequently cancer targeting accuracy, resulting in poorer clinical outcomes and increased health care costs. We have developed and patented the Breathe Well Audio Visual (AV) biofeedback device, to improve breathing regularity. Our goal is to gather critical scientific information and reach commercial proof-of-concept objectives that will allow us to attract investment to establish a viable medical device enterprise.
Biocompatible Synthetic Conduits To Treat Vascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$421,818.00
Summary
Clinically available synthetic conduits used in vascular repair and bypass are fundamentally incompatible with the vasculature. They cause inflammation at the site of implantation and increase the risk of blood clots forming. We have developed a unique method of binding bioactive protein layers to the surface of all polymeric materials and have shown a significant improvement in their compatibility. Grafts coated using our technology stand to dramatically improve the treatment of vascular diseas ....Clinically available synthetic conduits used in vascular repair and bypass are fundamentally incompatible with the vasculature. They cause inflammation at the site of implantation and increase the risk of blood clots forming. We have developed a unique method of binding bioactive protein layers to the surface of all polymeric materials and have shown a significant improvement in their compatibility. Grafts coated using our technology stand to dramatically improve the treatment of vascular disease.Read moreRead less
Development Of An Intra-Operative Tool For Tumour Margin Assessment During Surgery
Funder
National Health and Medical Research Council
Funding Amount
$599,472.00
Summary
The objective of this study is to develop and evaluate a surgical probe that uses novel terahertz technology to guide surgical excision. As an example, approximately 3,000 breast cancer patients per year require a second surgical procedure because of tumour identified close to the edge of tissue removed during surgery. There is a clinical need for an accurate, real-time and non-destructive technique to assess tumour margins during surgery. This tool could also be used for any surgery that requir ....The objective of this study is to develop and evaluate a surgical probe that uses novel terahertz technology to guide surgical excision. As an example, approximately 3,000 breast cancer patients per year require a second surgical procedure because of tumour identified close to the edge of tissue removed during surgery. There is a clinical need for an accurate, real-time and non-destructive technique to assess tumour margins during surgery. This tool could also be used for any surgery that requires preservation of normal tissue.Read moreRead less